U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Esepapogene zalarnarepvec expressed Lymphocytic choriomeningitis virus pre-glycoprotein polyprotein GP
337VS7CVU8
Other
General
Record Details
Names
3
Identifiers
1
Concept Definition
Relationships
1
Esepapogene zalarnarepvec expressed Lymphocytic choriomeningitis virus pre-glycoprotein polyprotein GP
337VS7CVU8
Other
General
Approval Year
Unknown
149,124
Record Details
Substance Class
Concept
Record UNII
337VS7CVU8
Record Status
Validated (UNII)
Record Version
9
8
7
6
5
4
3
2
1
Names
3
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
Esepapogene zalarnarepvec expressed Lymphocytic choriomeningitis virus pre-glycoprotein polyprotein GP
Common Name
English
TT1-E7E6 expressed pre-glycoprotein polyprotein GP
Preferred Name
English
VSV-GP128 expressed Lymphocytic choriomeningitis virus pre-glycoprotein polyprotein GP
Common Name
English
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
1
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
337VS7CVU8
PRIMARY
Showing 1 to 1 of 1 entries
Previous
1
Next
Concept Definition
This is a non-substance concept
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
VA2XPJ9DMK
Esepapogene zalarnarepvec
VECTOR->EXPRESSED PROTEIN
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
This is a non-substance concept
